These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28712298)

  • 1. The Fragment Network: A Chemistry Recommendation Engine Built Using a Graph Database.
    Hall RJ; Murray CW; Verdonk ML
    J Med Chem; 2017 Jul; 60(14):6440-6450. PubMed ID: 28712298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the future for fragment-based drug discovery?
    Keserű GM; Hann MM
    Future Med Chem; 2017 Sep; 9(13):1457-1460. PubMed ID: 28795595
    [No Abstract]   [Full Text] [Related]  

  • 6. FilTer BaSe: A web accessible chemical database for small compound libraries.
    Kolte BS; Londhe SR; Solanki BR; Gacche RN; Meshram RJ
    J Mol Graph Model; 2018 Mar; 80():95-103. PubMed ID: 29328995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
    Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products.
    Murray JB; Roughley SD; Matassova N; Brough PA
    J Med Chem; 2014 Apr; 57(7):2845-50. PubMed ID: 24520903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
    Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
    Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graph mining for SAR transfer series.
    Gupta-Ostermann D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2012 Apr; 52(4):935-42. PubMed ID: 22436016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Molecular Promiscuity Evaluation Through Assay Profiles.
    Avram S; Curpan R; Bora A; Neanu C; Halip L
    Pharm Res; 2018 Oct; 35(11):240. PubMed ID: 30338400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the coverage of medicinal chemistry-relevant space in commercial fragments screening.
    Mok NY; Brenk R; Brown N
    J Chem Inf Model; 2014 Jan; 54(1):79-85. PubMed ID: 24405118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
    Wollenhaupt J; Metz A; Barthel T; Lima GMA; Heine A; Mueller U; Klebe G; Weiss MS
    Structure; 2020 Jun; 28(6):694-706.e5. PubMed ID: 32413289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
    Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Otting G; Huang D; Caflisch A
    J Med Chem; 2009 Aug; 52(15):4860-8. PubMed ID: 19572550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
    Huang D
    Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening.
    Eurtivong C; Reynisson J
    Mol Inform; 2019 Mar; 38(3):e1800068. PubMed ID: 30345657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules and their role in effective preclinical target validation.
    Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
    Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.